DeviceTalks Podcast Network

Structural Heart Talks: Edwards Lifesciences

Technology EN ↓ 6 episodes

Over 60 years ago, engineer Miles Lowell Edwards and surgeon Dr. Albert Starr launched a company and an industry by developing the first commercially available artificial heart valve. Today, Edwards Lifesciences is focusing its attention on developing life-saving and groundbreaking devices that can help patients with heart valve disease. In this podcast series, we'll talk with the Edwards Lifesciences leaders who are adding to this great MedTech story. This podcast is powered by DeviceTalks and is part of the DeviceTalks Podcast Network.

Be sure to visit the podcast's website and support the creator: www.devicetalks.com

Author

DeviceTalks Podcast Network

Episodes

Edwards’ Joe Nuzzolese on planning for disruption, prioritizing patients & automating supply chains Video 15.04.2025 35:14

In this episode of Structural Heart Talks, Joe Nuzzolese, corporate VP of global supply chain and quality at Edwards Lifesciences, shares how the company has built a resilient and responsive supply chain capable of withstanding significant disruptions—pandemic included—without missing a single patient case. Nuzzolese explains how Edwards takes a "plan, make, source, deliver" approach, and why MedT...

Todd Brinton shares lessons on mentorship, Edwards’ culture and advancing heart failure innovation Video 14.04.2025 40:46

In this episode of Structural Heart Talks , Todd Brinton, MD, Chief Scientific Officer & CVP, Advanced Technology at Edwards Lifesciences, discusses Edwards’ vision of future innovative technologies that elevate patient care and expand the possibilities of structural heart therapies. Brinton reflects on his journey from biomedical engineering to pioneering roles in MedTech, including his work...

Edwards’ Larry Wood discusses TAVR evolution, new clinical paradigms, and addressing treatment gaps Video 14.04.2025 37:15

In this episode of Structural Heart Talks, Larry Wood, Corporate VP and Group President, Transcatheter Aortic Valve Replacement and Surgical Structural Heart at Edwards Lifesciences, discusses the transformative journey of transcatheter aortic valve replacement (TAVR) and the SAPIEN valve. Wood reflects on the innovation that enables minimally invasive heart valve replacement, which has become the...

Edwards surgical structural heart SVP Markowitz highlights culture, innovation, and making an impact Video 14.04.2025 22:23

In this episode of Structural Heart Talks, Wayne Markowitz, General Manager and SVP, Surgical Structural Heart at Edwards Lifesciences, discussed the evolving landscape of the structural heart space, emphasizing the sharpened focus at Edwards under new leadership. Markowitz highlights the importance of the surgical structural heart business, with a strong emphasis on innovation and collaboration w...

Daveen Chopra discusses Edwards’ mitral and tricuspid focus, PASCAL and EVOQUE, and patient impacts Video 14.04.2025 37:21

In the inaugural episode of our newest podcast, Structural Heart Talks, we sit down with Daveen Chopra, Corporate VP and GM of Transcatheter Mitral and Tricuspid Therapies (TMTT) at Edwards Lifesciences. In the episode, Chopra discusses the unique challenges of advancing therapies for the mitral and tricuspid valves, which have historically been more difficult to treat than the aortic valve due to...

What to expect on the Structural Heart Talks: Edwards Lifesciences podcast Video 14.04.2025 0:55

Nearly 70 years ago, engineer Miles Lowell Edwards and surgeon Dr. Albert Starr launched a company and an industry by developing the first commercially available artificial heart valve. Today, Edwards Lifesciences is focusing its attention on developing life-saving and groundbreaking devices that can help patients with heart disease. Hosted by Tom Salemi, Editorial Director of DeviceTalks, and wit...